Evidence map›Paper›PMID 25838474›Full record

ArticleGenome announcements2015

High-Quality Draft Genome Sequence of Actinobacterium Kibdelosporangium sp. MJ126-NF4, Producer of Type II Polyketide Azicemicins, Using Illumina and PacBio Technologies.

Yasushi Ogasawara, Norah Torrez-Martinez, Anthony D Aragon, Benjamin J Yackley, Jessica A Weber, Anitha Sundararajan, Thiruvarangan Ramaraj, Jeremy S Edwards, Charles E Melançon

Open access · diamondAbstract read
In one paragraph

Article in Genome announcements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yasushi OgasawaraDepartment of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico, USA.
Norah Torrez-MartinezDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Anthony D AragonDepartment of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico, USA.
Benjamin J YackleyDepartment of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico, USA.
Jessica A WeberDepartment of Biology, University of New Mexico, Albuquerque, New Mexico, USA.
Anitha SundararajanNational Center for Genome Resources (NCGR), Santa Fe, New Mexico, USA.
Thiruvarangan RamarajNational Center for Genome Resources (NCGR), Santa Fe, New Mexico, USA.
Jeremy S Edwards
Charles E Melançoncemelanc@unm.edu.
University of New Mexico · USNational Center for Genome Resources · USNew Mexico Cancer Center · US

Funding

NM-INBRE Sequencing and Bioinformatics CoreP20GM103451 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI Charlotte C. Gard · 2012 to 2026
$61.2M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Haplotype Resolved Sequencing TechnologyR01HG006876 · NHGRI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2013 to 2015
$1.3M
NCI NIH HHS P30 CA118100NHGRI NIH HHS R01 HG006876NIGMS NIH HHS P20 GM103451
6 · The paper itself

Abstract

Here, we report the high-quality draft genome sequence of actinobacterium Kibdelosporangium sp. MJ126-NF4, producer of the type II polyketide azicemicins, obtained using Illumina and PacBio sequencing technologies. The 11.75-Mbp genome contains >11,000 genes and 22 polyketide and nonribosomal peptide natural product gene clusters.

Identifiers

PMID25838474
PMCPMC4384478
OpenAlexW2320447964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.